BACKGROUND: Infliximab therapy has short-term benefits in children with moderate-to-severe Crohn's disease (CD). We assessed the long-term outcome of infliximab maintenance therapy in children with CD. METHODS: We performed a multicenter cohort study of 729 pediatric patients with CD enrolled in the...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!